Results 51 to 60 of about 4,338,055 (298)

Chronic Renal Failure in India [PDF]

open access: yesRenal Failure, 1997
A prospective study of all new cases of chronic renal failure (CRF) including inservice referrals was done at our hospital over a period of 1 year from May 1994 to April 1995. The diagnosis of CRF was based on clinical, laboratory, and radiological features. Kidney biopsies were done when indicated.
S, Mittal   +4 more
openaire   +2 more sources

Homocysteine as a predictive biomarker in early diagnosis of renal failure susceptibility and prognostic diagnosis for end stages renal disease

open access: yes, 2016
Glomerular filtration rate and/or creatinine are not accurate methods for renal failure prediction. This study tested homocysteine (Hcy) as a predictive and prognostic marker for end stage renal disease (ESRD).
Hatem K. Amin   +5 more
core   +1 more source

Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the EUSTAR Cohort

open access: yesArthritis Care &Research, EarlyView.
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato   +27 more
wiley   +1 more source

Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS‐DAI)

open access: yesArthritis Care &Research, EarlyView.
Objective Vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic syndrome (VEXAS) syndrome is characterized by a complex spectrum of inflammatory and hematologic manifestations. Clinical research to identify effective therapies is urgently needed but is hindered by the lack of validated outcome measures.
Kevin Byram   +25 more
wiley   +1 more source

In-center hemodialysis and COVID 19 infection [PDF]

open access: yesJournal of Preventive Epidemiology, 2020
Seyed Seifollah Beladi Mousavi   +2 more
doaj   +1 more source

Caregiver Perspectives on the Burden of Disease and Treatment in Uncontrolled Gout

open access: yesArthritis Care &Research, EarlyView.
Objective Uncontrolled gout (UG) refers to persistently elevated serum urate (SU) levels >6 mg/dL and ongoing gout symptoms despite use of urate‐lowering therapy (ULT). The objective of this study was to evaluate the burden associated with informal caregiving for individuals with UG.
Angelo Gaffo   +6 more
wiley   +1 more source

Pseudoporphyria secondary to renal failure

open access: yes, 2017
Introduction . Pseudoporphyria is a rare disease associated with chronic renal failure. Symptoms of pseudoporphyria may develop in response to UV exposure and medications.
Remigiusz Szumiński   +3 more
core   +1 more source

Rheumatoid Arthritis, Frailty, and Outcomes of Surgical Hospitalizations: A National Population‐Based Analysis

open access: yesArthritis Care &Research, EarlyView.
Objective Hospitalization, particularly for surgery, represents a period of heightened stress. We evaluated how frailty attenuates the association of rheumatoid arthritis (RA) with negative health outcomes after elective noncardiac surgery. Methods We conducted a cross‐sectional study using the National Inpatient Sample (2018 to 2020), including adults
Ali Yazdanyar   +5 more
wiley   +1 more source

هپاتیت B در مبتلایان به بیماری مرحله‌ی پایانی کلیه، تحت درمان با همودیالیز

open access: yesمجله دانشکده پزشکی اصفهان, 2016
با وجود همه‌ی روش‌های پیش‌گیری، ویروس هپاتیت B (HBV یا Hepatitis B virus)، که می‌تواند عامل ایجاد هپاتیت حاد و مزمن، سیروز و سرطان کبد باشد، همچنان در بسیاری از مناطق به صورت اندمیک باقی مانده است و بیش از 350 میلیون نفر در جهان ناقل مزمن این ویروس هستند.
Seyed Seifollah Beladi-Mousavi   +4 more
doaj  

Promising role of sodium-glucose cotransporter-2 inhibitors in IgA nephropathy [PDF]

open access: yesJournal of Nephropharmacology, 2023
Samaneh Zandifar, Shokouh Shayanpour
doaj   +1 more source

Home - About - Disclaimer - Privacy